Hims & Hers David B. Wells converts 1,051 stock units
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. director David B. Wells reported an exercise/conversion of 1,051 restricted stock units into 1,051 shares of Class A common stock on November 13, 2026. He held 230,859 shares directly afterward. The RSUs were granted in lieu of $30,000 in third-quarter 2026 director retainer fees and will vest in full on the company’s next quarterly vesting date; the grant price was $28.53.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1 | 1,051 | $0.00 | $0.00 |
| Exercise | Class A Common Stock F1 | 1,051 | -- | -- |
Footnotes (1)
- F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the third quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $30,000 by the grant price of $28.53. The RSUs will vest in full on the Company's next quarterly vesting date.
Key Figures
Key Terms
Restricted Stock Units technical
contingent right technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why were David B. Wells’s HIMS restricted stock units granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.